Markets:

Overview

News

Currencies

International

Treasuries

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

13.79 -1.31 (-8.64%)

Streaming Delayed Price Updated: 12:17 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Where Atara Biotherapeutics Stands With Analysts ↗

August 09, 2022

Analysts have provided the following ratings for Atara Biotherapeutics (NASDAQ:ATRA) within the last quarter:

Via Benzinga

Atara Biotherapeutics: Q2 Earnings Insights ↗

August 08, 2022

Atara Biotherapeutics (NASDAQ:ATRA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Atara Biotherapeutics...

Via Benzinga

Atara Biotherapeutics Announces Second Quarter 2022 Financial Results and Corporate Strategy Update

August 08, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

ATARA ALERT: Bragar Eagel & Squire, P.C. is Investigating Atara Biotherapeutics, Inc. on Behalf of Atara Stockholders and Encourages Investors to Contact the Firm

August 05, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Mizuho On Atara Biotherapeutics - Distinguish Between Small Numbers And Science Failure ↗

July 13, 2022

Via Benzinga

Where Atara Biotherapeutics Stands With Analysts ↗

July 13, 2022

Atara Biotherapeutics (NASDAQ:ATRA) has observed the following analyst ratings within the last quarter:

Via Benzinga

Atara Biotherapeutics Shares Are Plummeting - Read Why ↗

July 13, 2022

Via Benzinga

ATARA ALERT: Bragar Eagel & Squire, P.C. is Investigating Atara Biotherapeutics, Inc. on Behalf of Atara Stockholders and Encourages Investors to Contact the Firm

August 04, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 04, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference

August 03, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022

August 01, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

August 01, 2022

On Monday, 92 companies set new 52-week lows.

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Atara Biotherapeutics, Inc. with Losses of $100,000 to Contact the Firm

July 28, 2022

From The Schall Law Firm

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

July 25, 2022

On Monday, 100 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 22, 2022

During Friday's session, 61 companies made new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 13, 2022

Via Benzinga

Dow Drops 100 Points; IronSource Shares Spike Higher ↗

July 13, 2022

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving higher on Wednesday. The annual inflation rate in the US increased to 9.1% in June, the highest level...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022 ↗

July 20, 2022

Upgrades

Via Benzinga

Nasdaq Turns Higher; Delta Air Lines Earnings Miss Estimates ↗

July 13, 2022

U.S. stocks pared some losses midway through trading, with the Nasdaq Composite turning higher on Wednesday. The annual inflation rate in the US increased to 9.1% in June, the highest level since...

Via Benzinga

Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday ↗

July 14, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 13, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

U.S. Stocks Are Trading Lower As Inflation Rate Accelerates To This Level ↗

July 13, 2022

U.S. stocks traded lower this morning following the release of inflation data for June.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗

July 13, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program ↗

July 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 13, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 13, 2022

Good morning, investors! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket ↗

July 13, 2022

Gainers

Via Benzinga

Boeing, PriceSmart And 80 Biggest Movers From Yesterday ↗

July 13, 2022

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 12, 2022

Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.

Via Benzinga

Atara Biotherapeutics Announces Completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS

July 12, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.